Francesco Albano

70PUBLICATIONS
154CO-AUTHORS
Medical infection agents (incl. prions)Medical mycologyHaematological tumoursMedical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (70)

|Aug 04, 2026
FLT3-ITD Measurable Residual Disease in Acute Myeloid Leukemia: Recommended, but Not Yet Self-Sufficient.

|Jul 14, 2026
Effects of immunosuppressive and biological drugs in patients with asymptomatic monoclonal gammopathies (MGUS or smoldering myeloma) and concomitant autoimmune disorders: Results from the real-life MUSA study.

|Jul 08, 2026
Leukemic architecture as a framework for risk stratification in NPM1-mutated acute myeloid leukemia.

|Jun 08, 2026
How unfitness criteria can make a difference in treating AML patients with hypomethylating agents and venetoclax.

|May 20, 2026
One Grammar, Many Labels: Revisiting the Continuum of Myeloid Neoplasms.

|Mar 28, 2026
Early Ibrutinib Dose Modifications in CLL: A Post Hoc Analysis of the Real-World EVIdeNCE Study.

Stefano Molica, Potito Rosario Scalzulli, Lydia Scarfò

Pageof 12

Frequent Collaborators

14 joint publications

Pellegrino Musto

11 joint publications

Cosimo Cumbo

7 joint publications

Francesco Passamonti

7 joint publications

Francesco Tarantini